These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18574133)

  • 21. Default mode network connectivity in stable vs progressive mild cognitive impairment.
    Petrella JR; Sheldon FC; Prince SE; Calhoun VD; Doraiswamy PM
    Neurology; 2011 Feb; 76(6):511-7. PubMed ID: 21228297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between cerebral atrophy and number of present teeth in elderly individuals with cognitive decline.
    Egashira R; Umezaki Y; Mizutani S; Obata T; Yamaguchi M; Tamai K; Yoshida M; Makino M; Naito T
    Exp Gerontol; 2021 Feb; 144():111189. PubMed ID: 33285222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease.
    Karas G; Sluimer J; Goekoop R; van der Flier W; Rombouts SA; Vrenken H; Scheltens P; Fox N; Barkhof F
    AJNR Am J Neuroradiol; 2008 May; 29(5):944-9. PubMed ID: 18296551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease.
    Spulber G; Niskanen E; MacDonald S; Smilovici O; Chen K; Reiman EM; Jauhiainen AM; Hallikainen M; Tervo S; Wahlund LO; Vanninen R; Kivipelto M; Soininen H
    Neurobiol Aging; 2010 Sep; 31(9):1601-5. PubMed ID: 18829136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study.
    Bettermann K; Arnold AM; Williamson J; Rapp S; Sink K; Toole JF; Carlson MC; Yasar S; Dekosky S; Burke GL
    J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):436-44. PubMed ID: 21236699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease.
    Calvini P; Chincarini A; Gemme G; Penco MA; Squarcia S; Nobili F; Rodriguez G; Bellotti R; Catanzariti E; Cerello P; De Mitri I; Fantacci ME; ;
    Med Phys; 2009 Aug; 36(8):3737-47. PubMed ID: 19746807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
    Misra C; Fan Y; Davatzikos C
    Neuroimage; 2009 Feb; 44(4):1415-22. PubMed ID: 19027862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
    Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND
    Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment.
    Ten Kate M; Barkhof F; Visser PJ; Teunissen CE; Scheltens P; van der Flier WM; Tijms BM
    Alzheimers Res Ther; 2017 Sep; 9(1):73. PubMed ID: 28899429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry.
    Ho AJ; Hua X; Lee S; Leow AD; Yanovsky I; Gutman B; Dinov ID; Leporé N; Stein JL; Toga AW; Jack CR; Bernstein MA; Reiman EM; Harvey DJ; Kornak J; Schuff N; Alexander GE; Weiner MW; Thompson PM;
    Hum Brain Mapp; 2010 Apr; 31(4):499-514. PubMed ID: 19780044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI.
    Wolz R; Heckemann RA; Aljabar P; Hajnal JV; Hammers A; Lötjönen J; Rueckert D;
    Neuroimage; 2010 Aug; 52(1):109-18. PubMed ID: 20382238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
    den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
    Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
    van de Pol LA; van der Flier WM; Korf ES; Fox NC; Barkhof F; Scheltens P
    Neurology; 2007 Oct; 69(15):1491-7. PubMed ID: 17923611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corpus callosum atrophy and cognitive decline in early Alzheimer's disease: longitudinal MRI study.
    Zhu M; Wang X; Gao W; Shi C; Ge H; Shen H; Lin Z
    Dement Geriatr Cogn Disord; 2014; 37(3-4):214-22. PubMed ID: 24193144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.
    McEvoy LK; Holland D; Hagler DJ; Fennema-Notestine C; Brewer JB; Dale AM;
    Radiology; 2011 Jun; 259(3):834-43. PubMed ID: 21471273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment.
    Falini A; Bozzali M; Magnani G; Pero G; Gambini A; Benedetti B; Mossini R; Franceschi M; Comi G; Scotti G; Filippi M
    Neuroimage; 2005 Jul; 26(4):1159-63. PubMed ID: 15878675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease.
    Sluimer JD; van der Flier WM; Karas GB; van Schijndel R; Barnes J; Boyes RG; Cover KS; Olabarriaga SD; Fox NC; Scheltens P; Vrenken H; Barkhof F
    Eur Radiol; 2009 Dec; 19(12):2826-33. PubMed ID: 19618189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.